TAK-480

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameTAK-480
Drug Alias NameTAK-480
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeurokinin 2 receptor antagonists
TargetsNeurokinin 2 receptor
Therapy Area/IndicationsIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTakeda Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsIrritable Bowel Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A